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ABSTRACT: The importance of ciguatoxins (CTXs) in seafood safety and their emerging occurrence in locations far away from 
tropical areas highlight the need for simple and low-cost methods for the sensitive and rapid detection of these potent marine toxins 
to protect seafood consumers. Herein, an electrochemical immunosensor for the detection of CTXs is presented. A sandwich config-
uration is proposed, using magnetic beads (MBs) as immobilisation supports for two capture antibodies, with their combination 
facilitating the detection of CTX1B, CTX3C, 54-deoxyCTX1B and 51-hydroxyCTX3C. PolyHRP-streptavidin is used for the detec-
tion of the biotinylated detector antibody. Experimental conditions are first optimised using colorimetry, and these conditions are 
subsequently used for electrochemical detection on electrode arrays. Limits of detection at the pg/mL level are achieved for CTX1B 
and 51-hydroxyCTX3C. The applicability of the immunosensor to the analysis of fish samples is demonstrated, attaining detection 
of CTX1B at contents as low as 0.01 µg/kg, and providing results in correlation with those obtained using mouse bioassay (MBA) 
and cell-based assay (CBA), as well as liquid chromatography coupled to high-resolution mass spectrometry (LC-ESI-HRMS). This 
user-friendly bioanalytical tool for the rapid detection of CTXs can be used to mitigate ciguatera risk and contribute to the protection 
of consumer health. 
Ciguatera fish poisoning (CFP) is the most common and one of 
the most relevant seafood-borne diseases worldwide, affecting 
from 10,000 to 500,000 people per year, and probably even 
more due to underdiagnosis and underreporting.1 CFP is char-
acterised by severe neurological, gastrointestinal and cardiovas-
cular disorders that usually abate within a few days or weeks 
but can persist for months or years.2 CFP is caused by the in-
gestion of fish contaminated with ciguatoxins (CTXs), potent 
lipophilic marine toxins with complex chemical structures3 pro-
duced by microalgae of the genus Gambierdiscus4-7 and Fu-
kuyoa6,8 that accumulate in fish through the food webs. There 
are several types of CTXs depending on their chemical struc-
ture. CTXs have been historically classified according to their 
geographical origin into Pacific (P)9-11, Caribbean (C)12- 13 and 
Indic (I)14-15 CTXs. However, CTXs are emerging in places not 
previously expected according to their latitude, particularly in 
Europe. In recent years, several species of Gambierdiscus have 
been found in the Canary Islands,16-20 where several CFP out-
breaks have also occurred.21-23 CTXs have also been detected in 
fish from other areas of the Macaronesia, i.e. Azores and Ma-
deira archipelagos (Portugal).24-25 Gambierdiscus sp.,26 G. aus-
trales27 and F. paulensis28 have been recorded in the Mediterra-
nean Sea. 
To protect consumer health, the United States Food and Drug 
Administration (US FDA) proposed guidance levels of ≤0.01 
μg/kg of CTX1B equivalent toxicity in fish.29 In Europe, alt-
hough the legislation requires that no fish products containing 
CTXs are placed on the market (Regulation (EC) No. 
853/2004), no regulatory limits have been established and no 
details regarding the analytical methodology that should be em-
ployed have been provided. Other parts of the world, such as 
Australia or New Zealand, provide guidelines on the susceptible 
fish species and the local areas where fish may be toxic30 and, 
in Japan, the sale of barracuda and other fish species associated 
with CFP is banned, but no specific regulations for CTXs are 
provided.31-32 
The mouse bioassay (MBA) has been the most widely used 
method to detect CTXs. Due to its insufficient detection capa-
bility and ethical concerns, other methods have been developed, 
including high-performance liquid chromatography coupled 
with mass spectrometry, cell-based assays (CBAs) and receptor 
binding assays.33 The analysis of CTXs in fish is hampered by 
the fact that certified reference calibrants and materials are not 
readily available. This issue together with the chemical com-
plexity of CTXs have hindered the production of specific anti-
bodies. Hokama and co-workers produced anti-CTX polyclonal 
antibodies (pAbs) that were used for the development of some 
immunoassays34 and two immunostrip tests, marketed as Cigua-
Check35-36 and Ciguatect kit.37 These antibodies showed high 
cross-reactivity with another marine toxin, okadaic acid, and the 
performance of the tests was very controversial as both false 
positive and false negative results were obtained.38-40 In fact, 
fish determined as positive in Israel,41 the first and only report 
of ciguateric fish in the Mediterranean, had been analysed using 
only the Cigua-Check kit, and confirmation of CTXs in fish 
from this area is in fact still pending. On the other hand, syn-
thetic haptens as an alternative to natural CTXs were exploited 
for the production of monoclonal antibodies (mAbs) that were 
subsequently used in immunoassays and observed to have high 
enough specificity and sensitivity.42-48 Taking into account 
these successful results and with the aim to move towards com-
pact and automated devices, the development of an electro-
chemical immunosensor for the detection of CTXs is under-
taken for the first time. 
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In this work, three different mAbs (3G8, 10C9 and 8H4) that 
specifically bind to one of the wings of the four principal con-
geners of CTXs (CTX1B, CTX3C, 51-hydroxyCTX3C and 54-
deoxyCTX1B) are used to develop a sandwich immunosensor. 
Magnetic beads (MBs) are exploited as a support to provide an 
enlarged surface area for the immobilisation of mAbs, to 
shorten the analysis time and to minimise matrix effects. The 
applicability of the immunosensor to the analysis of fish is suc-
cessfully demonstrated, enabling the discrimination between 
contaminated and non-contaminated samples and the detection 
of CTX1B contents at 0.01 µg/kg. Liquid chromatography cou-
pled to electrospray ionisation high-resolution mass spectrome-
try (LC-ESI-HRMS) analysis confirmed the presence of 
CTX1B in fish. The availability of this user-friendly bioanalyt-
ical tool for the rapid detection of CTXs can mitigate the risk of 
ciguatera and contribute to consumer health protection. 
EXPERIMENTAL SECTION 
Reagents and solutions. Dynabeads M-270 Carboxylic Acid 
(2 x 109 beads/mL) were supplied by Invitrogen (Life Technol-
ogies, S.A., Alcobendas, Spain). Potassium phosphate monoba-
sic, potassium phosphate dibasic, potassium chloride, 4-mor-
pholineethanesulfonic acid (MES) hydrate, N-(3-dimethyla-
minopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), Tween®-20, bovine serum album 
(BSA), anti-mouse IgG (whole molecule)-horseradish peroxi-
dase antibody produced in rabbit (IgG-HRP), and 3,3’,5,5’-tet-
ramethylbenzidine (TMB) liquid substrate were purchased from 
Sigma-Aldrich (Tres Cantos, Spain). PolyHRP-streptavidin 
was obtained from Thermo Fisher (Barcelona, Spain). Milli-Q 
water (Millipore, Bedford, USA) was used to prepare all solu-
tions. For the extractions, acetone and diethyl ether were ob-
tained from Chem-lab (Zedelgem, Belgium), ethanol from J. T. 
Baker (Madrid, Spain), and methanol and n-hexane from Hon-
eywell (Barcelona, Spain). For LC-ESI-HRMS, HPLC-MS 
grade acetonitrile and water were supplied by Chem-lab 
(Zedelgem, Belgium), and ammonium formate and formic acid 
by Sigma-Aldrich (Tres Cantos, Spain). CTX1B standard solu-
tion was obtained from Prof. Richard J. Lewis (The Queensland 
University, Australia) and calibrated (correction factor of 90%) 
in relation to the NMR-quantified CTX1B standard solution 
from Prof. Takeshi Yasumoto (Japan Food Research Laborato-
ries, Japan). NMR-quantified 51-hydroxyCTX3C standard so-
lution was kindly provided by Prof. Takeshi Yasumoto. 3G8, 
10C9 and 8H4 mAbs had been prepared by immunising mice 
with keyhole limpet hemocyanin (KLH) conjugates of ration-
ally designed synthetic haptens (Oguri et al., 1999, 2003; 
Nagumo et al., 2001, 2004; Tsumuraya et al., 2006, 2010, 2012, 
2014). Biotin labelling of the 8H4 mAb was performed with the 
EZ-Link™ NHS-PEG4 Biotinylation Kit from Thermo Fisher 
(Barcelona, Spain) following the manufacturer’s instructions. 
Unreacted NHS-PEG4-Biotin was removed using Zeba Spin 
Desalting Columns (7 kDa MWCO, 2mL) included in the kit. 
Equipment. Magnetic separation was performed using a Mag-
neSphere Technology Magnetic Separation Stand (for twelve 
0.5-mL or 1.5-mL tubes) and a PolyATtract System 1000 Mag-
netic Separation Stand (for one 15-mL tube) from Promega Cor-
poration (Madison, WI, USA). Colorimetric measurements 
were performed with a Microplate Reader KC4 from BIO-TEK 
Instruments, Inc. (Vermont, USA). Gen5 software was used to 
collect and evaluate data. Screen-printed electrode arrays 
(DRP-8x110), a boxed connector (DRP-CAST8X) and a mag-
netic support (DRP-MAGNET8X) were purchased from 
Dropsens S.L. (Oviedo, Spain). The arrays consist of 8 carbon 
working electrodes of 2.5 mm in diameter, each with its own 
counter and silver reference electrodes. Amperometric meas-
urements were performed with a PalmSens potentiostat con-
nected to an 8-channel multiplexer (MUX8) (Houte, The Neth-
erlands). PalmSens PC software was used to collect and evalu-
ate data. 
Fish samples and extraction. Sampling was performed at var-
ious locations of the Indian Ocean close to Réunion and Mau-
rice Islands. Variola louti (N=9), Lutjanus bohar (N=6) and 
Thyrsitoides marleyi (N=1) specimens were collected. Fishing 
dates and sites are summarised in Table 1. Fish samples were 
processed as previously described.49 Briefly, 10 g of fish flesh 
homogenate were heated at 70 °C for 15 min in a water bath. 
Subsequently, 20 mL of acetone was added and the sample mix-
ture was homogenised with an Ultra-turrax blender at 17500 xg 
for 5 min. The sample mixture was centrifuged at 3000 xg for 
10 min to obtain the supernatant. The pellet was re-extracted 
with acetone, and supernatants were pooled, filtered with 0.45 
µm nylon filters and evaporated at 55 °C. The dried extract was 
dissolved in 5 mL of methanol:water (9:1, v:v) and partitioned 
twice with 5 mL of n-hexane, and the n-hexane phases were 
discarded. The aqueous methanol solution was dried by rotary 
evaporation. The residue was dissolved in 5 mL of ethanol:wa-
ter (1:3, v:v) and partitioned twice with 5 mL of diethyl ether. 
Diethyl ether fractions were pooled and dried. The residue was 
re-suspended in 4 mL of methanol and kept at -20 °C until ana-
lysed. For calculation purposes, 1 mL of extract contains 2.5 g 
equivalents of fish flesh. 
Conjugation of the capture mAbs to MBs. 3G8 and 10C9 
mAb-MB conjugates were prepared as follows: (1) 8 µL of MB 
suspension were transferred to a tube and washed twice with 
500 µL of MES (25 mM MES, pH 5.0) with vigorous mixing; 
for the washing steps, the tube was placed on the magnetic sep-
aration stand and the washing solution was removed; (2) 40 µL 
of 50 mg/mL EDC and 40 µL of 50 mg/mL NHS were added 
and incubated for 30 min; (3) the activated MBs were washed 
twice with MES; (4) 80 µL of 3G8 or 10C9 mAb in MES (from 
1/50 to 1/3200 dilution for protocol optimisation and 1/50 dilu-
tion for the final assay) were added and incubated for 1 hour; 
(5) the mAb-MB conjugate was washed three times with PBS-
Tween (0.1 M PBS, 0.05% v/v Tween®-20, pH 7.2) and re-sus-
pended in 80 µL of the same buffer. All incubations were per-
formed at room temperature and with slow tilt rotation. When 
the amounts of MB varied, the volumes were adjusted propor-
tionally. To confirm the conjugation of the mAbs to the MBs 
and optimise the dilution to be used, 25 µL of mAb-MB conju-
gate were transferred to a new tube and incubated with 250 µL  
of anti-mouse IgG-HRP in PBS-Tween containing 1% w/v BSA 
(PBS-Tween-BSA) (1/1000 dilution) for 30 min, and after two 
washing steps with PBS-Tween, 20 µL of the immunoconjugate 
were transferred to a new tube, the supernatant was removed, 
and 125 µL of TMB were added, followed by a 5 min incuba-
tion. Finally, the tube was placed on the magnetic separation 
stand and 100 µL taken for absorbance reading at 620 nm.
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Table 1. Fish data and CTX1B equivalent contents (pg/g) (± standard deviation) obtained in their analysis using MBA, CBA, color-
imetric immunoassay and electrochemical biosensor. 
Species Fishing date Fishing site MBA CBA Immunoassay Immunosensor 
Variola louti January 2013 Saint-Gilles, Réunion nd nd nd nd 
Variola louti March 2013 Saint-Gilles, Réunion nd nd nd nd 
Variola louti March 2013 Saint-Gilles, Réunion nd nd nd nd 
Variola louti March 2013 Saint-Gilles, Réunion nd nd nd nd 
Variola louti April 2013 Saint-Gilles, Réunion nd nd nd nd 
Variola louti July 2003 
La Pérouse Seamount, 
Réunion 
++ 9.74 ± 0.47 33.44 ± 2.04 26.14 ± 1.56 
Variola louti April 2004 
La Pérouse Seamount, 
Réunion 
++ 81.66 ± 9.77 45.81 ± 13.99 44.40 ± 20.37 
Variola louti January 2003 
La Pérouse Seamount, 
Réunion 
++ 580.06 ± 86.36 107.31 ± 5.18 97.41 ± 34.36 
Variola louti†* March 2015 Maurice +++ 2104.00 ± 224.43 279.77 ± 3.69 247.85 ± 35.56 
Lutjanus bohar September 2002 
La Pérouse Seamount, 
Réunion 
++ 21.75 ± 0.30 9.19 ± 0.51 7.36 ± 0.64 
Lutjanus bohar August 2003 
La Pérouse Seamount, 
Réunion 
++ 440.68 ± 20.94 9.02 ± 1.01 7.72 ± 0.90 
Lutjanus bohar August 2003 
La Pérouse Seamount, 
Réunion 
++ 552.70 ± 83.91 22.76 ± 0.54 18.92 ± 5.41 
Lutjanus bohar December 2003 
La Pérouse Seamount, 
Réunion 
++ 506.47 ± 86.36 27.12 ± 0.92 27.73 ± 8.79 
Lutjanus bohar* February 2003 
La Pérouse Seamount, 
Réunion 
++ 1296.73 ± 181.60 149.46 ± 8.21 134.66 ± 32.8 
Lutjanus bohar January 2002 
La Pérouse Seamount, 
Réunion 
+++ 2481.03 ± 727.47 142.46 ± 2.51 147.04 ± 28.44 
Thyrsitoides marleyi†* June 2015 Saint-Paul, Réunion +++ 600.48 ± 68.86 88.21 ± 9.50 78.12 ± 34.11 
† Fish individuals involved in a poisoning case 
* Fish individuals analysed by LC-ESI-HRMS 
nd: not detected; ++: intermediate toxicity; +++: strong toxicity 
 
Colorimetric immunoassay and electrochemical im-
munosensor. Sandwich immunoassays were performed in 0.5-
mL tubes following this protocol: (1) 150 µL of mAb-MB con-
jugates (75 µL of each mAb-MB conjugate) were exposed to 75 
µL of CTX1B or 51-hydroxyCTX3C standard solution (conge-
ners chosen as model CTXs) or fish extract (previously evapo-
rated and re-suspended in PBS-Tween) for 30 min; (2) after 
three washing steps with PBS-Tween, a blocking step was per-
formed with PBS-Tween-BSA (PBS-Tween containing 2% w/v 
BSA) for 30 min; (3) the conjugates were washed three times 
with PBS-Tween and incubated with 75 µL of biotin-8H4 mAb 
in PBS-Tween-BSA (from 1/50 to 1/4000 dilution for protocol 
optimisation and 1/2000 dilution for the final assay) for 30 min; 
(4) three washing steps were performed with PBS-Tween and 
75 µL of polyHRP-streptavidin in PBS-Tween-BSA (from 
1/500 to 1/5000 dilution for protocol optimisation and 1/1000 
dilution for the final assay) were added and incubated for 30 
min; (6) finally, three washing steps were performed in PBS-
Tween and the content of each tube was re-suspended in 75 µL 
of the same buffer. All incubations were performed at room 
temperature and with slow tilt rotation. When the amounts of 
MB varied, the volumes were adjusted proportionally. Subse-
quent steps differed slightly between the immunoassay and the 
immunosensor as described below. For the colorimetric immu-
noassay: (7) 10 µL of immunocomplexes were transferred to a 
new tube and the supernatant was removed; (8) 125 µL of TMB 
were added, followed by a 10 minute incubation; (9) tubes were 
placed on the magnetic separation stand and 100 µL of solution 
were taken for absorbance reading at 620 nm. Measurements 
were performed in duplicate or triplicate. For the electrochemi-
cal immunosensor: (7) 10 µL of immunocomplexes were placed 
on each working electrode of the 8-electrode array with a mag-
netic support on the back, the magnetic immunocomplex was 
captured and the supernatant was removed; (8) 10 µL of TMB 
were then added, followed by a 2 min incubation; (9) the TMB 
reduction current was measured using amperometry, applying 
−0.2 V (vs. Ag) for 5 s. Measurements were performed in trip-
licate or quadruplicate. 
Mouse bioassay. The protocol was based on a standard method 
developed by ANSES (CATNAT-10). Fish extracts were solu-
bilised in Tween-60 1-5% v/v saline solution, and then injected 
into three mice (male, OF1; 20 ± 2 g) by intraperitoneal (i.p.) 
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route. The mice were observed continuously during the first 2 h 
and then monitored regularly up to 24 h after injection. The in-
terpretation of the results was based on the time-to-death and 
symptoms (profuse diarrhoea, piloerection, respiratory disor-
ders, dyspnoea and transient pre-erectional cyanosis of the pe-
nis, which can lead to priapism). 
Cell-based assay. The CBA was performed as previously de-
scribed.50 Briefly, neuro-2a (N2a) cells (ATCC, CCL131) were 
seeded in a 96-well microplate in 200 mL of RPMI medium 
containing 5% v/v fetal bovine serum (RPMI-FBS) at 42,500 
cells per well and incubated at 37 °C in a 5% CO2 humid atmos-
phere for 24 h. Prior to exposure to CTX1B standard solution 
or fish extract, some N2a cells were pre-treated with ouabain 
and veratridine at 1 and 0.1 mM, respectively. CTX1B standard 
solution or fish extract were dried, reconstituted in 200 mL of 
RPMI-FBS medium, serially diluted, and 10 µL were added to 
the wells with and without ouabain/veratridine pre-treatment. 
After 24 h, cell viability was measured using the MTT assay. 51 
Measurements were performed in triplicate. 
LC-ESI-HRMS analysis. One V. louti individual caught in 
March 2015, one L. bohar individual caught in February 2003 
and a T. marleyi individual were analysed by LC-ESI-HRMS. 
An Orbitrap-Exactive HCD (Thermo Fisher Scientific, Bremen, 
Germany) mass spectrometer equipped with a heated elec-
trospray source (H-ESI II), a Surveyor MS Plus pump and an 
Accela Open AS auto-sampler kept at 15 °C (Thermo Fisher 
Scientific, San José, California) were used for the LC-ESI-
HRMS analysis. The chromatographic separation was per-
formed on a Kinetex XB-C18 reversed phase (100 mm × 2.1 
mm, 2.6μm) (Phenomenex, Torrance, CA, USA) at a flow rate 
of 250 µL/min. Mobile phase A was water and B was acetoni-
trile/water (95:5), both containing 2 mM ammonium formate 
and 0.1% v/v formic acid. The gradient elution program was: 
30% B 1 min, 30-40% B 2 min, 40-50% B 1 min, 50-90% B 5 
min, 90% B 3 min and return to initial conditions for re-equili-
bration (11 min 30% B). A 5-µL injection volume was used. 
The total duration of the method was 25 min. The analysis was 
carried out in electrospray positive ionisation (H-ESI+). 
CTX1B was used to optimize the source, transmission and 
HRMS conditions in positive mode. The final parameters were: 
spray voltage of 4.0 kV, capillary temperature of 275 °C, heater 
temperature of 300 °C, sheath gas flow rate of 35 psi and auxil-
iary gas flow rate of 10 (arbitrary units). Capillary voltage of 
47.5 V, tube lens voltage of 186 V and skimmer voltage of 18 
V were used. Nitrogen was employed as sheath, auxiliary and 
collision gas. The mass range was m/z 400-1500 in full scan 
acquisition mode. The resolution was 50,000 (m/z 200, FWHM) 
at a scan rate 2Hz, the automatic gain control was set as "bal-
anced" (1e6) with a maximum injection time of 250 ms. Data 
were processed with Xcalibur 2.2 SP1 software (Thermo Fisher 
Scientific, Bremen, Germany). Automatic identification/quan-
tification was performed. The peaks found were confirmed by 
the exact mass of [M+H]+, [M+NH4]
+ and [M+Na]+ diagnostic 
ions with a mass accuracy of ± 3ppm (mass extraction window) 
and the retention time window. The following restrictive crite-
ria were also used: elements considered were restricted in ac-
cordance with CTXs molecular formulae and adduct signals [C 
55 to 70, H 64 to 110, O 11 to 25, N 0 to 1, and cations (Na) 0 
to 1], the isotopic pattern was matched and the charge, the ring 
double bond equivalents and nitrogen rule were taken into ac-
count. Additionally, the monoisotopic pattern (M+1 ion) of 
these signals was used to assist in the further confirmation of 
the toxin identity. The relative ion intensities between 
[M+NH4]
+, [M+Na]+ and their M+1 ions were calculated and 
matched taking into account a tolerance according to the EU 
Decision 2002/657/EC. An external standard calibration was 
carried out from 1 to 100 ng/mL of CTX1B with a limit of de-
tection (LOD) of 0.3 ng/mL. The sum of the areas of 
[M+H]++[M+NH4]
++[M+Na]+ signals was used for quantifica-
tion purposes. 
RESULTS AND DISCUSSION 
The concept of the immunosensor is schematically depicted in 
Fig. 1. On one side, two different mouse mAbs, 3G8 mAb able 
to bind to the left wing of CTX1B and 54-deoxyCTX1B48 and 
10C9 mAb able to bind to the left wing of CTX3C and 51-hy-
droxyCTX3C,46 were immobilised separately on MBs and used 
as capture antibodies. On the other side, 8H4 mouse mAb, 
which binds to the right wing of CTX1B, CTX3C, 54-deox-
yCTX1B and 51-hydroxyCTX3C,46 was biotinylated and used 
as a detector antibody. Following successive incubations of the 
magnetic immunocomplexes with the analyte and the biotinyl-
ated 8H4 mAb, polyHRP-streptavidin was used for signal re-
porting. Signal amplification was achieved by replacing the 
conventional HRP-streptavidin by polyHRP-streptavidin, a 
conjugate that contains a polymer with approximately 20 HRP 
molecules per streptavidin molecule.  
 
Figure 1. Representation of the electrochemical immunosensor 
for the detection of CTXs. 
Optimisation of the experimental conditions. Capture mAbs 
were conjugated to carboxylic acid-modified MBs through car-
bodiimide coupling using EDC-NHS. Several 3G8 mAb dilu-
tions were used to optimise the amount of antibody. Anti-mouse 
IgG-HRP was used to detect the immobilised antibody. As ex-
pected, absorbance values increased with increasing amounts of 
antibody (Fig. S1). No saturation of the MBs was observed even 
with the highest antibody concentration tested (1/50 mAb dilu-
tion). This dilution was thus selected for further experiments as 
well as for 10C9 mAb. 
The amount of biotinylated 8H4 mAb was optimised using 3G8 
mAb at 1/50 dilution, CTX1B at 1000 and 0 pg/mL and poly-
HRP-streptavidin at 1/1000 dilution. The best signal-to-noise 
absorbance ratio was achieved with 1/2000 biotinylated 8H4 
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mAb dilution (Fig. S2), which was selected for further experi-
ments. These results demonstrated the correct performance of 
the system as well as the successful biotinylation of the 8H4 
mAb, which maintains its affinity for the right wing of CTX1B 
once biotinylated. 
PolyHRP-streptavidin was selected to amplify the signals and 
its concentration was optimised to achieve the best signal-noise 
ratio. The 3G8 mAb-MB conjugates were exposed to CTX1B 
at 100 and 0 pg/mL and biotinylated 8H4 mAb at 1/2000 dilu-
tion, and subsequently incubated with a range of polyHRP-
streptavidin dilutions (Fig. S3). Very low non-specific values 
were observed. In the presence of CTX1B, absorbance values 
obtained from 1/500 to 1/2000 dilutions did not show signifi-
cant differences and the signal observed at a 1/5000 dilution 
was only slightly lower. Although saturation of the response 
was achieved even with a 1/2000 polyHRP-streptavidin dilu-
tion, a 1/1000 dilution was selected for further experiments to 
ensure polyHRP-streptavidin availability. 
Colorimetric characterisation. Using the optimised condi-
tions, the calibration curve for CTX1B was constructed with 10 
µL of 3G8 mAb-MB conjugate (equivalent to 1 µL of MBs). As 
expected, a dose-dependent response was observed (Fig. 2A). 
The calibration curve was blank-subtracted and fitted to a sig-
moidal logistic four-parameter equation. The LOD and limit of 
quantification (LOQ) were calculated using 3 and 10 times the 
standard deviation of the blank value (no CTX) and were deter-
mined to be 3.29 and 17.52 pg/mL, respectively. The calibration 
curve for 51-hydroxyCTX3C was then constructed using 10 µL 
of 10C9 mAb-MB conjugate. Again, a dose-dependent re-
sponse was observed, with a slight saturation at high toxin con-
centrations (Fig. 2B). LOD and LOQ values of 6.17 and 28.31 
pg/mL were obtained, respectively. These values are lower than 
those attained with the colorimetric ELISA (LOD of 280 pg/mL 
for CTX1B)43 but higher than those achieved with the fluores-
cence ELISA (LODs of 0.16 and 0.10 pg/mL for CTX1B and 
51-hydroxyCTX3C, respectively).47 
Since the purpose of the immunosensor is to detect as many 
CTX analogues as possible, both capture antibodies should be 
able to work together with no interferences from each other. To 
evaluate this, 10 µL of 3G8 mAb-MB conjugate and 10 µL of 
10C9 mAb-MB conjugate were mixed and calibration curves 
for CTX1B and 51-hydroxyCTX3C were constructed. The 
presence of twice the amount of MBs did not interfere in the 
recognition event or the measurement, as no significant differ-
ences were observed as compared to the calibration curves ob-
tained using individual conjugates. Thus, in principle the im-
munosensor should be able to detect CTX1B and 51-hy-
droxyCTX3C simultaneously, as well as other analogues recog-
nised by the mAbs, providing a global response. It is important 
to add that no cross-reactivity of 3G8 mAb-MB conjugates and 
10C9 mAb-MB conjugates to 51-hydroxyCTX3C and CTX1B 
(at 500 pg/mL), respectively, was observed. 
Electrochemical immunosensor. To develop the electrochem-
ical biosensor, the magnetic immunocomplexes were trans-
ferred to 8-electrode arrays. Electrochemical calibration curves 
for CTX1B and 51-hydroxyCTX3C were first constructed us-
ing 10 µL of 3G8 mAb-MB or 10 µL of 10C9 mAb-MB conju-
gates, respectively (Fig. 2C and 2D). No saturation of the am-
perometric response was observed at the highest CTX concen-
tration tested, with the dynamic ranges being well over two or-
ders of magnitude for both CTXs. LOD and LOQ values of 1.96 
and 2.94 pg/mL, respectively, were obtained for CTX1B, and 
3.59 and 13.91 pg/mL for 51-hydroxyCTX3C. These values are 
lower than those obtained with the colorimetric approach, but 
still higher than the ones obtained with the fluorescence ELISA. 
Nevertheless, the electrochemical biosensor provides added ad-
vantages in terms of cost, the possibility to be integrated into 
compact analytical devices, and portability. 
Subsequently, 10 µL of 3G8 mAb-MB conjugate and 10 µL of 
10C9 mAb-MB were mixed and immobilised on electrode ar-
rays. Calibration curves for CTX1B and 51-hydroxyCTX3C 
were constructed, and results did not differ from those achieved 
with each individual conjugate. The modification of the elec-
trode surface with twice the amount of magnetic immunocom-
plexes did not hamper the electrochemical measurement. Simi-
lar to the colorimetric approach, CTX1B, 51-hydroxyCTX3C 
and the other CTXs analogues recognised by the mAbs should 
be detected together without a loss of sensitivity. 
Repeatability and reproducibility of the immunosensor for 100 
pg/mL CTX1B were evaluated performing multiple measure-
ments on the same (intra-day precision) and different days (in-
ter-day precision), respectively. The relative standard deviation 
(RSD) value for the measurements performed on the same day 
with the same mAb-MB conjugate pool was 12% (N=3). The 
RSD value for the measurements performed on different days 
with different mAb-MB conjugate pools was 14% (N=6). These 
values show appropriate reliability for the whole procedure in-
cluding both immunosensor preparation and amperometric 
transduction. 
 
Figure 2. Calibration curves for CTX1B (A and C) and 51-hydroxyCTX3C (B and D) obtained using the colorimetric immunoassay 
(A and B) and the electrochemical immunosensor (C and D) (N=3). Curves are background-subtracted (Abs value = 0.089 ± 0.007; 
Intensity = 417 ± 121 nA). 
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Fish matrix effects and recovery. The effect of the fish matrix 
on the responses of the immunoassay and the immunosensor 
(using both mAb-MB conjugates together) was evaluated using 
a V. louti individual that had previously been determined as neg-
ative for CTXs by CBA. Absorbance and current intensity val-
ues at different extract dilutions were not significantly different 
from those obtained from the corresponding blanks (no fish ex-
tract), even at 2500 mg/mL. This experiment indicates that there 
is no non-specific adsorption of the capture antibody and/or the 
polyHRP-streptavidin. 
To evaluate if the presence of fish matrix may interfere in the 
response of the immunoassay and the immunosensor towards 
CTXs, 100 pg/mL of CTX1B were spiked into several dilutions 
of the same V. louti extract. Absorbance and current intensity 
values were compared with those attained with the same amount 
of CTX1B in buffer. Recovery percentages are shown in Table 
2. Although the highest matrix concentration tested had not 
shown any effect in the previous experiment, CTX detection 
was affected. As the matrix was diluted, recovery percentages 
increased reaching nearly 90%. Although the matrix affects 
CTX quantification, these preliminary recovery values can be 
used as correction factors to be applied to the CTX quantifica-
tions provided by the immunoassay and the immunosensor in 
the analysis of naturally-contaminated fish. 
To evaluate matrix effects between fish individuals, different 
CTX1B concentrations (from 3 to 100 pg/mL) were spiked into 
two non-contaminated V. louti extracts at 2500 mg/mL. Accord-
ing to the ANCOVA test, no significant differences were ob-
served between individuals (P=0.65 for the immunoassay and 
P=0.38 for the immunosensor). Nonetheless, a more exhaustive 
analysis (including different fish species, of different size and 
from different geographical locations) would be required to bet-
ter define the correction factors.
Table 2. CTX1B recovery values obtained in the analysis of a non-contaminated V. louti individual at different matrix concentrations 
using the colourimetric immunoassay and the electrochemical immunosensor. Values are expressed in percentages (%) and calculated 
with reference to the CTX1B spiking level of 100 pg/mL. 
 2500 mg/mL 1000 mg/mL 500 mg/mL 250 mg/mL 100 mg/mL 
Colorimetry 65 ± 3 77 ± 3 86 ± 6 88 ± 4 89 ± 3 
Electrochemistry 58 ± 17 72 ± 2 76 ± 14 83 ± 17 89 ± 9 
Analysis of fish samples spiked at 0.01 µg/kg CTX1B. Alt-
hough regulatory limits for CTXs in fish have not yet been is-
sued by official organisations, an important feature of the im-
munosensor presented herein should be the ability to detect at 
least CTX1B at 0.01 µg/kg. Effective LOQs (eLOQs) were cal-
culated from the calibration curves constructed from the 
CTX1B spiked V. louti extracts at 2500 mg/mL. The eLOQs 
achieved were 0.01 µg/kg and 0.002 µg/kg for the assay and 
biosensor, respectively, which are in agreement with the LOQs 
calculated from the calibration curve in buffer after applying the 
corresponding correction factors. The precision of the LOQ 
value was lower than 15% for both immunosensing tools. Thus, 
in principle, the developed tools should be able to detect 
CTX1B at 0.01 µg/kg. 
To demonstrate this experimentally, the non-contaminated V. 
louti extract was spiked with 25 pg/mL of CTX1B and analysed 
at 2500 mg/mL (which corresponds to 0.01 µg/kg of CTX1B in 
the fish flesh). Once the absorbance and current intensity values 
were obtained, the previous recovery values achieved in the 
analysis of non-contaminated V. louti extract at 2500 mg/mL 
were used as correction factors and applied to the quantifica-
tions of the CTXs. Compared to the spiked level, the recovery 
values were 99% and 103% for the colorimetric immunoassay 
and the electrochemical biosensor, respectively.  
It is important to note that the FDA guidance level is provided 
in CTX1B equivalent toxicity in fish. This equivalent toxicity 
is the composite toxicity in relation to CTX1B of the contami-
nated fish, in which several CTX congeners could be present. 
Thus, values achieved by the immunosensing tools can be di-
rectly compared with US FDA guidance levels when only 
CTX1B is present in the sample. The immunosensing tools are 
able to detect CTX3C, 51-hydroxyCTX3C and 54-deox-
yCTX1B in addition to CTX1B, but in an extent not necessarily 
related to their toxicity. Other non-structurally-related ana-
logues are not detected by the immunosensing tools developed.  
Analysis of naturally-contaminated fish samples. Results for 
the MBA and CTXs contents determined by the immunoassay, 
the immunosensor and CBA are summarised in Table 1 (Table 
S1 shows the raw data before applying the correction factors). 
Negative and positive individuals as determined by MBA and 
CBA were also negative and positive by the immunoassay and 
the immunosensor. An excellent correlation was obtained when 
comparing the CTX1B equivalent contents obtained using the 
immunosensor and the immunoassay (r = 0.997; P < 0.001) 
(Fig. 3A). A good correlation was also observed between the 
immunosensor and the CBA (r = 0.891; P < 0.001) (Fig. 3B). 
The higher levels of CTXs obtained using the CBA as compared 
to the immunoassay and the immunosensor can be explained by 
the different recognition principles. Whereas the immunochem-
ical tools detect analogues that possess specific wings in their 
structures (structural immunorecognition), CBA detects ana-
logues that activate voltage-gated sodium channels (toxicologi-
cal recognition). Thus, CBA could indeed be detecting a higher 
number of CTXs or could also be detecting other compounds 
different from CTXs that activate voltage-gated sodium chan-
nels. Since the cross-reactivity factors (CRFs) are not neces-
sarily the same as the toxic equivalency factors (TEFs) and 
many of them are still unknown, quantification between the as-
says cannot be always be directly compared.  
To confirm the presence of CTXs, LC-ESI-HRMS analysis of 
three naturally-contaminated individuals was performed. The 
analysis revealed the presence of CTX1B in the V. louti indi-
vidual at 1609 pg/g (Fig. 4, Fig. S4). The presence of other CTX 
congeners was not confirmed. LC-ESI-HRMS determined 
around a 6-fold higher CTXs content than that obtained using 
the developed immunosensing tools. However, no CTXs were 
detected in the L. bohar and T. marleyi individuals analysed us-
ing LC-ESI-HRMS, despite the high toxicities or CTXs con-
tents observed by MBA, CBA and the immunosensing tools. It 
is important to note that the LOQ of LC-ESI-HRMS is much 
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higher than the LOQs attained with the immunosensing tools 
(i.e. ~400 pg/g vs. ~2-10 pg/g). Additionally, whereas LC-ESI-
HRMS quantifies individual CTX analogues, the immunosens-
ing tools reported here provide a global response of all CTXs 
detected, being more useful for the detection of CTXs contents 
in multi-toxin samples where each analogue is at a low concen-
tration. 
A higher number of samples should be analysed to provide sta-
tistically sound comparisons with LC-ESI-HRMS analysis. 
Samples with higher CTXs contents and/or pre-concentration 
and clean-up steps for samples to be analysed by LC-ESI-
HRMS would be necessary, this work being beyond the scope 
of this work. Nevertheless, the comparison of the results ob-
tained with the immunosensing tools and CBA shows a good 
correlation, with each method having advantages and limita-
tions, and their application provide complementary infor-
mation. 
 
Figure 3. Correlations between CTX1B equivalent contents in 
fish provided by the electrochemical immunosensor and the col-
orimetric immunoassay (A) and the electrochemical im-
munosensor and CBA (B). 
Figure 4. Extract ion chromatogram of CTX1B at m/z 
1111.5836 [M+H]+, 1128.6102 [M+NH4]
+, 1133.5656 
[M+Na]+ and [M+H+NH4+Na]
+ of CTX1B standard and V. 
louti extract. 
CONCLUSIONS 
An electrochemical immunosensor for the determination of 
CTXs in fish has been developed. Taking advantage of the sand-
wich configuration using magnetic beads as immobilisation 
supports and polyHRP-streptavidin for signal amplification, to-
gether with the benefits provided by electrochemical detection, 
the biosensor showed an excellent analytical performance in 
terms of sensitivity and reproducibility for the detection of 
CTX1B and 51-hydroxyCTX3C. The immunosensor was suc-
cessfully applied to the analysis of fish samples, enabling the 
detection of CTX1B at 0.01 µg/kg and showing a good correla-
tion with CTX levels determined by the CBA. Compared to 
CBA, the electrochemical immunosensor can tolerate higher 
matrix concentrations. Whilst the LOD for CTX1B achieved by 
the immunosensor is slightly higher than using CBA, the effec-
tive LOQ is similar. The magneto-immunosensor provides ro-
bustness, specificity, simplicity and rapidity in contrast with 
CBA, which requires working with “live” materials that need 
maintenance. On the other hand, the immunosensor achieved a 
LOQ over two orders of magnitude lower than LC-ESI-HRMS, 
is considerably more cost-effective, and does not require so-
phisticated instrumentation. Due to its lower cost, ease of oper-
ation, portability and lack of need for maintenance, there is no 
doubt that the electrochemical biosensor can be easily imple-
mented in monitoring and research, clearly addressing the sig-
nificant challenges faced for the reliable and accurate detection 
of CTXs at the point-of-need. 
ASSOCIATED CONTENT 
Supporting Information 
The Supporting Information is available free of charge on the ACS 
Publications website. Conjugation of different capture mAb dilu-
tions to MBs. Optimisation of the biotinylated detector mAb dilu-
tion. Optimisation of the polyHRP-streptavidin dilution. (PDF) 
AUTHOR INFORMATION 
Corresponding Author 
* M. Campàs, IRTA, Ctra. Poble Nou km 5.5, 43540 Sant Carles 
de la Ràpita, Spain, monica.campas@irta.cat 
Notes 
The authors declare no competing financial interest. 
ACKNOWLEDGMENTS 
The research has received funding from the Ministerio de 
Economía, Industria y Competitividad (MINECO), the Agencia 
Estatal de Investigación (AEI) and the Fondo Europeo de Desar-
rollo Regional (FEDER) through the CIGUASENSING 
(BIO2017-87946-C2-2-R) project. The authors acknowledge Prof. 
Takeshi Yasumoto for kindly providing the 51-hydroxyCTX3C 
standard solution. The authors also acknowledge support from 
CERCA Programme/Generalitat de Catalunya. G. Gaiani 
acknowledges IRTA and Universitat Rovira i Virgili for her PhD 
grant (2018PMF-PIPF-19). 
REFERENCES 
1. Friedman, M.; Fernandez, M.; Backer, L.; Dickey, R.; Bernstein, J.; 
Schrank, K.; Kibler, S.; Stephan, W.; Gribble, M.; Bienfang, P., An 
updated review of ciguatera fish poisoning: clinical, epidemiological, 
environmental, and public health management. Mar. Drugs 2017, 15, 
72. 
2. Lehane, L.; Lewis, R. J., Ciguatera: recent advances but the risk re-
mains. Int. J. Food Microbiol. 2000, 61, 91-125. 
3. Murata, M.; Legrand, A. M.; Ishibashi, Y.; Yasumoto, T., Structures 
of ciguatoxin and its congener. J. Am. Chem. Soc. 1989, 111, 8929-
8931. 
4. Chinain, M.; Darius, H. T.; Ung, A.; Cruchet, P.; Wang, Z.; Ponton, 
D.; Laurent, D.; Pauillac, S., Growth and toxin production in the cig-
uatera-causing dinoflagellate Gambierdiscus polynesiensis (Di-
nophyceae) in culture. Toxicon 2010, 56, 739-750. 
 




























































5. Caillaud, A.; de la Iglesia, P.; Barber, E.; Eixarch, H.; Mohammad-
Noor, N.; Yasumoto, T.; Diogene, J., Monitoring of dissolved cigua-
toxin and maitotoxin using solid-phase adsorption toxin tracking de-
vices: Application to Gambierdiscus pacificus in culture. Harmful Al-
gae 2011, 10, 433-446. 
6. Litaker, R. W.; Holland, W. C.; Hardison, D. R.; Pisapia, F.; Hess, 
P.; Kibler, S. R.; Tester, P. A., Ciguatoxicity of Gambierdiscus and Fu-
kuyoa species from the Caribbean and Gulf of Mexico. PLoS One 2017, 
12, e0185776. 
7. Reverté, L.; Toldrà, A.; Andree, K. B.; Fraga, S.; de Falco, G.; 
Campàs, M.; Diogène, J., Assessment of cytotoxicity in ten strains of 
Gambierdiscus australes from Macaronesian Islands by neuro-2a cell-
based assays. J. Appl. Phycol. 2018, 30, 2447-2461. 
8. Lewis, R. J.; Inserra, M.; Vetter, I.; Holland, W. C.; Hardison, D. R.; 
Tester, P. A.; Litaker, R. W., Rapid extraction and identification of 
maitotoxin and ciguatoxin-like toxins from Caribbean and Pacific 
Gambierdiscus using a new functional bioassay. PLoS One 2016, 11, 
e0160006. 
9. Lewis, R. J., The changing face of ciguatera. Toxicon 2001, 39, 97-
106. 
10. Satake, M.; Fukui, M.; Legrand, A.-M.; Cruchet, P.; Yasumoto, T., 
Isolation and structures of new ciguatoxin analogs, 2, 3-dihy-
droxyCTX3C and 51-hydroxyCTX3C, accumulated in tropical reef 
fish. Tetrahedron Lett. 1998, 39, 1197-1198. 
11. Yasumoto, T.; Igarashi, T.; Legrand, A.-M.; Cruchet, P.; Chinain, 
M.; Fujita, T.; Naoki, H., Structural elucidation of ciguatoxin conge-
ners by fast-atom bombardment tandem mass spectroscopy. J. Am. 
Chem. Soc. 2000, 122, 4988-4989. 
12. Lewis, R.; Vernoux, J.P.; Brereton, M., Structure of Caribbean Cig-
uatoxin Isolated from Caranx Iatus. J. Am. Chec. Soc. 1998, 120, 24, 
5914-5920. 
13. Pottier, I.; Vernoux, J. P.; Jones, A.; Lewis, R. J., Characterisation 
of multiple Caribbean ciguatoxins and congeners in individual speci-
mens of horse-eye jack (Caranx latus) by highperformance liquid chro-
matography/mass spectrometry. Toxicon 2002, 40, 929-939. 
14. Hamilton, B.; Hurbungs, M.; Vernoux, J. P.; Jones, A.; Lewis, R. 
J., Isolation and characterisation of Indian Ocean ciguatoxin. Toxicon 
2002, 40, 685-693. 
15. Hamilton, B.; Hurbungs, M.; Jones, A.; Lewis, R. J., Multiple cig-
uatoxins present in Indian Ocean reef fish. Toxicon 2002, 40, 1347-
1353. 
16. Fraga, S., Riobó, P., Diogène, J., Paz, B., & Franco, J.M., 2004. 
11th International Conference on Harmful Algae, Capetown: 115. 
17. Fraga, S.; Rodríguez, F., Genus Gambierdiscus in the Canary Is-
lands (NE Atlantic Ocean) with description of Gambierdiscus silvae 
sp. nov., a new potentially toxic epiphytic benthic dinoflagellate. Pro-
tist 2014, 165, 839-853. 
18. Fraga, S.; Rodríguez, F.; Caillaud, A.; Diogène, J.; Raho, N.; Za-
pata, M., Gambierdiscus excentricus sp. nov. (Dinophyceae), a benthic 
toxic dinoflagellate from the Canary Islands (NE Atlantic Ocean). 
Harmful Algae 2011, 11, 10-22. 
19. Bravo, I.; Rodriguez, F.; Ramilo, I.; Rial, P.; Fraga, S., Ciguatera-
Causing Dinoflagellate Gambierdiscus spp. (Dinophyceae) in a Sub-
tropical Region of North Atlantic Ocean (Canary Islands): Morpholog-
ical Characterization and Biogeography. Toxins 2019, 11, 423. 
20. Rodríguez, F.; Fraga, S.; Ramilo, I.; Rial, P.; Figueroa, R. I.; Riobó, 
P.; Bravo, I., Canary Islands (NE Atlantic) as a biodiversity ‘hotspot’ 
of Gambierdiscus: Implications for future trends of ciguatera in the 
area. Harmful Algae 2017, 67, 131-143. 
21. Perez-Arellano, J.-L.; Luzardo, O. P.; Brito, A. P.; Cabrera, M. H.; 
Zumbado, M.; Carranza, C.; Angel-Moreno, A.; Dickey, R. W.; Boada, 
L. D., Ciguatera fish poisoning, Canary Islands. Emerg. Infect. Di. 
2005, 11, 1981. 
22. Boada, L. D.; Zumbado, M.; Luzardo, O. P.; Almeida-González, 
M.; Plakas, S. M.; Granade, H. R.; Abraham, A.; Jester, E. L.; Dickey, 
R. W., Ciguatera fish poisoning on the West Africa Coast: An emerging 
risk in the Canary Islands (Spain). Toxicon 2010, 56, 1516-1519. 
23. Bravo, J.; Suárez, F.; Ramírez, A.; Acosta, F., Ciguatera, an emerg-
ing human poisoning in Europe. J. Aquac. Mar. Biol 2015, 3, 00053. 
24. Silva, M.; Rodriguez, I.; Barreiro, A.; Kaufmann, M.; Neto, A.; 
Hassouani, M.; Sabour, B.; Alfonso, A.; Botana, L.; Vasconcelos, V., 
First report of ciguatoxins in two starfish species: Ophidiaster ophidi-
anus and Marthasterias glacialis. Toxins 2015, 7, 3740-3757. 
25. Costa, P.; Estevez, P.; Castro, D.; Soliño, L.; Gouveia, N.; Santos, 
C.; Rodrigues, S.; Leao, J.; Gago-Martínez, A., New insights into the 
occurrence and toxin profile of ciguatoxins in Selvagens Islands (Ma-
deira, Portugal). Toxins 2018, 10, 524. 
26. Aligizaki, K.; Nikolaidis, G., Morphological identification of two 
tropical dinoflagellates of the genera Gambierdiscus and Sinophysis in 
the Mediterranean Sea. J. Biol. Res.-Thessalon. 2008, 9, 75-82. 
27. Tudó, À.; Toldrà, A.; Andree, K. B.; Rey, M.; Fernández-Tejedor, 
M.; Campàs, M.; Diogène, J., First report of Gambierdiscus in the 
Western Mediterranean Sea (Balearic Islands). Harmful Algae News 
2018, 59, 22-23. 
28. Laza‐Martínez, A.; David, H.; Riobó, P.; Miguel, I.; Orive, E., 
Characterization of a strain of Fukuyoa paulensis (Dinophyceae) from 
the Western Mediterranean Sea. J. Eukaryot. Microbiol. 2016, 63, 481-
497. 
29. US FDA (United States Food and Drug Administration), 2011. Fish 
and Fishery Products Hazards and Controls Guidance, 4th ed., Diane 
Publishing Co., Philadelphia. 
30. FSANZ (Food Standards Australia New Zealand), 2006. A guide 
to the Australian Primary Production and Processing Standard for Sea-
food, Safe Seafood Australia, 2nd ed., Canberra. 
31. MHWL (Ministry of Health, Welfare, and Labour), 1953. A ban on 
domestic sales of barracuda. MHWL notification No. 20, June 22nd 
1953, Food Sanitation Law (Directorates) 2010, Shin-Nippon-Houki, 
Japan, 1389. 
32. MHWL (Ministry of Health, Welfare, and Labour), 2001., Han-
dling of ciguatera fish, Office memorandum, by MHWL to heads of 
quarantine stations, January 22nd 2001, Food Sanitation Law (Direc-
torates) 2010, Shin-Nippon-Houki, Japan, 202-203. 
33. Reverté, L.; Soliño, L.; Carnicer, O.; Diogène, J.; Campàs, M., Al-
ternative methods for the detection of emerging marine toxins: biosen-
sors, biochemical assays and cell-based assays. Mar. Drugs 2014, 12, 
5719-5763. 
34. Hokama, Y.; Banner, A.; Boylan, D., A radioimmunoassay for the 
detection of ciguatoxin. Toxicon 1977, 15, 317-325. 
35. Hokama, Y., A rapid, simplified enzyme immunoassay stick test 
for the detection of ciguatoxin and related polyethers from fish tissues. 
Toxicon 1985, 23, 939-946. 
36. Hokama, Y.; Shirai, L.; Iwamoto, L.; Kobayashi, M.; Goto, C.; 
Nakagawa, L., Assessment of a rapid enzyme immunoassay stick test 
for the detection of ciguatoxin and related polyether toxins in fish tis-
sues. Biol. Bull. 1987, 172, 144-153. 
37. Park, D., Detection of ciguatera and diarrheic shellfish toxins in 
finfish and shellfish with ciguatect kit. J. AOAC Int. 1995, 78, 533-
537. 
38. Bienfang, P.; DeFelice, S.; Dowling, A., Quantitative evaluation of 
commercially available test kit for ciguatera in fish. Food Nutr. Sci. 
2011, 2, 594. 
39. Ebesu, J. S.; Campora, C. E., Comment on “Quantitative evaluation 
of commercially available test kit for ciguatera in fish”. Food Nutr. Sci. 
2012, 3, 1233. 
40. Dickey, R.; Granade, H.; McClure, F., Evaluation of a solid-phase 
immunobead assay for detection of ciguatera-related biotoxins in Car-
ibbean finfish. Mem. Queensl. Mus. 1994, 34, 481-488. 
41. Bentur, Y.; Spanier, E., Ciguatoxin-like substances in edible fish 
on the eastern Mediterranean. Clin. Toxicol. 2007, 45, 695-700. 
42. Oguri, H.; Hirama, M.; Tsumuraya, T.; Fujii, I.; Maruyama, M.; 
Uehara, H.; Nagumo, Y., Synthesis-based approach toward direct sand-
wich immunoassay for ciguatoxin CTX3C. J. Am. Chem. Soc. 2003, 
125, 7608-7612. 
43. Nagumo, Y.; Oguri, H.; Tsumoto, K.; Shindo, Y.; Hirama, M.; Tsu-
muraya, T.; Fujii, I.; Tomioka, Y.; Mizugaki, M.; Kumagai, I., Phage-
display selection of antibodies to the left end of CTX3C using synthetic 
fragments. J. Immunol. Methods 2004, 289, 137-146. 
44. Tsumuraya, T.; Fujii, I.; Hirama, M., Production of monoclonal an-
tibodies for sandwich immunoassay detection of Pacific ciguatoxins. 
Toxicon 2010, 56, 797-803. 
9 
45. Tsumuraya, T.; Fujii, I.; Hirama, M., Preparation of anti-ciguatoxin 
monoclonal antibodies using synthetic haptens: sandwich ELISA de-
tection of ciguatoxins. J. AOAC Int. 2014, 97, 373-379. 
46. Tsumuraya, T.; Fujii, I.; Inoue, M.; Tatami, A.; Miyazaki, K.; 
Hirama, M., Production of monoclonal antibodies for sandwich immu-
noassay detection of ciguatoxin 51-hydroxyCTX3C. Toxicon 2006, 48, 
287-294. 
47. Tsumuraya, T.; Sato, T.; Hirama, M.; Fujii, I., Highly sensitive and 
practical fluorescent sandwich ELISA for ciguatoxins. Anal. Chem. 
2018, 90, 7318-7324. 
48. Tsumuraya, T.; Takeuchi, K.; Yamashita, S.; Fujii, I.; Hirama, M., 
Development of a monoclonal antibody against the left wing of cigua-
toxin CTX1B: Thiol strategy and detection using a sandwich ELISA. 
Toxicon 2012, 60, 348-357. 
49. Diogène, J.;Reverté, L., Rambla-Alegre, M.; del Rio, V.; de la Ig-
lesia, P.; Campàs, M.; Palacios, O.; Flores, C.; Caixach, J.; Ralijaona, 
C.; Razanajatovo, I.; Pirog, A.; Magalon, H.; Arnich, N.; Turquet, J.; 
Identification of ciguatoxins in a shark involved in a fatal food poison-
ing in the Indian Ocean. Sci. Rep. 2017, 7, 8240. 
50. Soliño, L.; Widgy, S.; Pautonnier, A.; Turquet, J.; Loeffler, C. R.; 
Quintana, H. A. F.; Diogène, J., Prevalence of ciguatoxins in lionfish 
(Pterois spp.) from Guadeloupe, Saint Martin, and Saint Barthélmy is-
lands (caribbean). Toxicon 2015, 102, 62-68 
51. Manger, R. L.; Leja, L. S.; Lee, S.   Y.; Hungerford, J. M.; We-
kell, M. M., Tetrazodium-based cell bioassay for neurotoxins active 
on voltage-sensitive sodium channels: semiautomated assay for sax-






  SUPPORTING INFORMATION 
 
Addressing the analytical challenges for the detection of ciguatoxins 
using an electrochemical biosensor 
Sandra Leonardo1, Greta Gaiani1, Takeshi Tsumuraya2, Masahiro Hirama2, Jean Turquet3, Núria Sa-
gristà1, Maria Rambla-Alegre1, Cintia Flores4, Josep Caixach4, Jorge Diogène1, Ciara K. O’Sullivan5,6, 
Carles Alcaraz1, Mònica Campàs1* 
1IRTA, Ctra. Poble Nou km 5.5, 43540 Sant Carles de la Ràpita, Spain 
2Department of Biological Sciences, Graduate School of Science, Osaka Prefecture University, Osaka 599-8570, Japan 
3Citeb, C/o CYROI, 2 Rue Maxime Rivière, 97490 Sainte Clotilde, La Réunion, France 
4Mass Spectrometry Laboratory/Organic Pollutants, IDAEA-CSIC, C. Jordi Girona 18, 08034 Barcelona, Spain 
5Departament d’Enginyeria Química, URV, Av. Països Catalans 26, 43007 Tarragona, Spain 
6ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain 
 
 
Table of contents 
Figure S1. Conjugation of different 3G8 capture mAb dilutions to MBs. 
Figure S2. Optimisation of the biotinylated 8H4 detector mAb dilution. 
Figure S3. Optimisation of the polyHRP-streptavidin dilution. 
Figure S4. HRMS exact mass spectra of CTX1B standard and extract of V. louti. 
Table S1. Fish data and CTX1B equivalent contents (pg/g) obtained in the analysis by colorimetric 








Figure S1. Conjugation of different 3G8 capture mAb dilutions to MBs. Signal is obtained after incuba-
tion of 3G8 mAb-MB conjugates with anti-mouse IgG-HRP and subsequent incubation with TMB. 
 
 
Figure S2. Optimisation of the biotinylated 8H4 detector mAb dilution. Dark grey bars show absorbance 
values after the incubation with different biotinylated 8H4 mAb dilutions in the presence of 1000 pg/mL 








































Figure S3. Optimisation of the polyHRP-streptavidin dilution. Dark grey bars show absorbance values 
after the incubation with different polyHRP-streptavidin dilutions in the presence of 100 pg/mL CTX1B. 




Figure S4. HRMS exact mass spectra of CTX1B standard and extract of V. louti. 
Table S1. Fish data and CTX1B equivalent contents (pg/g) obtained in the analysis by colorimetric im-
munoassay and electrochemical biosensor without applying the correction factors. 












































































































Species Fishing date Fishing site Immunoassay Immunosensor 
Variola louti January 2013 Saint-Gilles, Réunion nd nd 
Variola louti March 2013 Saint-Gilles, Réunion nd nd 
Variola louti March 2013 Saint-Gilles, Réunion nd nd 
Variola louti March 2013 Saint-Gilles, Réunion nd nd 
Variola louti April 2013 Saint-Gilles, Réunion nd nd 
Variola louti July 2003 La Pérouse Seamount, 
Réunion 
21.57 ± 1.32 18.79 ± 1.12 
Variola louti April 2004 La Pérouse Seamount, 
Réunion 
39.27 ± 12.00 33.57 ± 15.40 
Variola louti January 2003 La Pérouse Seamount, 
Réunion 
94.73 ± 4.57  80.83 ± 28.51 
Variola louti†* March 2015 Maurice 246.98 ± 3.26 205.66 ± 29.50 
Lutjanus bohar September 2002 La Pérouse Seamount, 
Réunion 
5.94 ± 0.33 4.24 ± 0.37 
Lutjanus bohar August 2003 La Pérouse Seamount, 
Réunion 
5.83 ± 0.66 4.45 ± 0.52 
Lutjanus bohar August 2003 La Pérouse Seamount, 
Réunion 
14.71 ± 0.35 10.91 ±3.12 
Lutjanus bohar December 2003 La Pérouse Seamount, 
Réunion 
17.53 ± 0.59 15.99 ± 5.07 
Lutjanus bohar February 2003 La Pérouse Seamount, 
Réunion 
131.94 ± 7.25 111.74 ± 27.21 
Lutjanus bohar January 2002 La Pérouse Seamount, 
Réunion 
125.76 ± 2.22 122.01 ± 23.60 
Thyrsitoides marleyi† June 2015 Saint-Paul, Réunion 77.87 ± 8.39 64.82 ± 28.30 
